Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (March 2024). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422 |
El Moussaoui, M., Guiot, J., FRIPPIAT, F., & Darcis, G. (May 2023). Une cause émergente de fatigue et de douleurs chroniques : l’affection post-COVID-19 ou COVID long. Revue Médicale de Liège, 78 (5-6), 299 - 304. |
Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7 |
Layios, N., Visée, C., Mistretta, V., Denooz, R., Maes, N., Descy, J., Frippiat, F., Marchand, S., & Grégoire, N. (2022). Modelled target attainment after temocillin treatment in severe pneumonia: systemic and epithelial lining fluid pharmacokinetics of continuous versus intermittent infusions. Antimicrobial Agents and Chemotherapy, 0205221. doi:10.1128/AAC.02052-21 |
Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386 |
GONCETTE, V., Layios, N., DESCY, J., & FRIPPIAT, F. (September 2021). Continuous infusion, therapeutic drug monitoring and outpatient parenteral antimicrobial therapy with ceftazidime/avibactam: a retrospective cohort study. Journal of Global Antimicrobial Resistance, 26, 15 - 19. doi:10.1016/j.jgar.2021.04.015 |
Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757 |
Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x |
FRIPPIAT, F., Vercheval, C., & Layios, N. (2020). Meropenem: continuous or extended infusion? Critical care (London, England), 24 (1), 192. doi:10.1186/s13054-020-02883-w |
GONCETTE, V., Layios, N., & Frippiat, F. (2020). Continuous infusion and outpatient parenteral antimicrobial therapy with ceftazidime-avibactam: evaluation of efficacy based on therapeutic drug monitoring [Paper presentation]. ECCMID 2020. |
Vercheval, C., DAMAS, P., & FRIPPIAT, F. (2020). Quality of documentation on antibiotic treatment in medical records: evaluation of the long-term impact of an antimicrobial stewardship intervention [Poster presentation]. 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Paris, France. |
DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0 |
DESCY, J., VISEE, C., FRIPPIAT, F., MEEX, C., LAYIOS, N., VAN BAMBEKE, F., & MELIN, P. (21 April 2018). Temocillin susceptibility testing with Vitek2® system and E-test® Are these methods reliable to determine temocillin MIC ? [Poster presentation]. ECCMID 2018. |
HALLEUX, D., Juriens, I., Delwaide, J., FRIPPIAT, F., LEONARD, P., BLETARD, N., & DETRY, O. (February 2018). Prise en charge multidisciplinaire d'une volumineuse hydatidose hepatique. Revue Médicale de Liège, 73 (2), 65-71. |
MARCHETTA, S., DULGHERU, R. E., Oury, C., FRIPPIAT, F., & Lancellotti, P. (2018). Une urgence bien souvent meconnue. Revue Médicale de Liège, 73 (5-6), 283-289. |
VISEE, C., LAYIOS, N., MISTRETTA, V., MAES, N., VAN BAMBEKE, F., & FRIPPIAT, F. (23 April 2017). Epithelial lining fluid penetration of temocillin administered by continuous infusion in critically ill patients with nosocomial pneumonia [Paper presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria. |
VISEE, C., FRIPPIAT, F., DESCY, J., MEEX, C., MELIN, P., MISTRETTA, V., VAN BAMBEKE, F., & LAYIOS, N. (22 April 2017). Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? [Poster presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria. |
Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528. |
Frippiat, F., Seidel, L., Denooz, R., DAMAS, P., Layios, N., & Moutschen, M. (2014). Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration. Open Forum Infectious Diseases. doi:10.1093/ofid/ofu052 |
KEUTGENS, A., SIMONI, P., DETREMBLEUR, N., FRIPPIAT, F., GIOT, J.-B., SPIRLET, F., AGHAZARIAN, S., DESCY, J., MEEX, C., HUYNEN, P., Melin, P., MULLER, N., GOTTSTEIN, B., CARLIER, Y., & Hayette, M.-P. (February 2013). FATAL ALVEOLAR ECHINOCOCCOSIS OF THE LUMBAR SPINE. Journal of Clinical Microbiology, 51 (2), 688-91. doi:10.1128/JCM.01906-12 |
Kaux, J.-F., LENELLE, J., FRIPPIAT, F., LE GOFF, C., BARTSCH, V., Crielaard, J.-M., & DIVE, D. (August 2011). Métastase septique dorsale secondaire d’un abcès rétropharyngé responsable d’une tétraparésie. Revue Neurologique, 167 (8-9), 638-640. doi:10.1016/j.neurol.2011.03.001 |
FRIPPIAT, F., & Moutschen, M. (2011). Syphilis treatment in the human immunodeficiency virus-infected patient: follow the guidelines. Clinical Infectious Diseases, 53 (8), 845. doi:10.1093/cid/cir513 |
Moutschen, P., Bourhaba, M., FRIPPIAT, F., GIOT, J.-B., MEURIS, C., Leonard, P., & Moutschen, M. (2011). A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. Journal of Clinical Virology, 50 (3), 247-8. doi:10.1016/j.jcv.2010.11.016 |
Vanmeerbeek, M., Burette, P., Giet, D., FRIPPIAT, F., & Brunet, S. (16 November 2010). Qu’avons-nous appris de la pandémie de grippe de 2009 ? [Paper presentation]. Enseignement post-universitaire, Liège, Belgium. |
Denooz, R., Frippiat, F., & Charlier, C. (2010). Simultaneous quantification of five Beta-lactam antibiotics in human plasma by HPLC-DAD: Clinical application for ceftazidime treatment in intensive care units. Acta Clinica Belgica, 65 (Suppl. 1), 24-30. doi:10.1179/acb.2010.105 |
Mukeba, D., Chandrikakumari, K., Giot, J.-B., Leonard, P., Meuris, C., Frippiat, F., & Moutschen, M. (2009). Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter, 14 (1), 9-11. doi:10.1111/j.1523-5378.2009.00651.x |
Mayasi, N., Chandrikakumari, K., Mukeba, D., GIOT, J.-B., Leonard, P., Hayette, M.-P., Moutschen, M., & Frippiat, F. (01 September 2007). A Patient with Hiv Infection, Cough, Asthenia, and Fever. Clinical Infectious Diseases, 45 (5), 662-3, 559-600. doi:10.1086/520656 |
Leclercq, P., Betz, R., Lambermont, B., Leonard, P., & Frippiat, F. (03 February 2007). When the book is wrong. The Lancet, 9559, 369-370. doi:10.1016/S0140-6736(07)60190-1 |
Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50. |
GIOT, J.-B., Mukeba Tshialala, D., Mayasi Ngongo, N., Frippiat, F., Leonard, P., & Moutschen, M. (2007). Avancees therapeutiques en pathologie infectieuse au cours de la derniere decennie. Revue Médicale de Liège, 62 (5-6, May-Jun), 377-83. |
Hayette, M.-P., Mukeba Tschialala, D., Meex, C., Frippiat, F., Leonard, P., Huynen, P., Melin, P., & De Mol, P. (2007). Disseminated Penicillium marneffei infection contrated in China [Poster presentation]. 2nd Pan african medical mycology conference PAMMS, Cape Town, South Africa, South Africa. |
Schrouff, I., VALDES SOCIN, H. G., Frippiat, F., de Leval, L., Soyeur, D., Radermecker, M., & Scheen, A. (2007). Endocardite infectieuse tricuspidienne comme cause d'une fievre d'origine indeterminee. Revue Médicale de Liège, 62 (11), 654-8. |
Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72 |
Bourhaba, M., GIOT, J.-B., Tshialala, D. M., Leonard, P., Frippiat, F., & Moutschen, M. (2006). L'Hantavirose fait encore parler d'elle. Revue Médicale de Liège, 61 (5-6, May-Jun), 322-8. |